Want to join the conversation?
In 2016, $BCR expects Vascular revenue growth to be 3-7%, Urology to be 8-11%, Oncology to be 5-8%, and Surgical Specialties to be 6-9%. These are constant currency growth rates, not organic. The company also said that it is only providing organic revenue growth guidance at the corporate level.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.